NasdaqGM - Delayed Quote USD
Intellia Therapeutics, Inc. (NTLA)
8.50
+0.43
+(5.26%)
At close: May 16 at 4:00:00 PM EDT
8.32
-0.18
(-2.12%)
After hours: May 16 at 7:41:49 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BASTA JAMES EDMUND General Counsel | Sale | Mar 4, 2025 | 111,925 |
| BHANJI MUNA Director | Sale | Apr 29, 2025 | 19,203 |
| CLARK ELIANA Chief Technology Officer | Sale | Mar 4, 2025 | 95,369 |
| DUBE MICHAEL P Officer | Stock Award(Grant) | Feb 28, 2025 | 59,640 |
| DULAC EDWARD J III Chief Financial Officer | Stock Award(Grant) | Feb 28, 2025 | 113,524 |
| HICKS DEREK Officer | Sale | Jan 3, 2025 | 59,878 |
| LEBWOHL DAVID Officer | Stock Award(Grant) | Feb 28, 2025 | 130,866 |
| LEONARD JOHN M Chief Executive Officer | Stock Award(Grant) | Feb 28, 2025 | 1,135,530 |
| SEPP-LORENZINO LAURA Officer | Sale | Jan 3, 2025 | 77,388 |
| VERWIEL FRANK Director | Sale | Jun 17, 2024 | 17,948 |
Related Tickers
BEAM Beam Therapeutics Inc.
17.89
+3.71%
EDIT Editas Medicine, Inc.
1.5100
+8.24%
CRSP CRISPR Therapeutics AG
38.77
+6.77%
PRME Prime Medicine, Inc.
1.5900
+26.19%
VERV Verve Therapeutics, Inc.
4.6300
+7.18%
CRBU Caribou Biosciences, Inc.
0.9384
+11.73%
IOVA Iovance Biotherapeutics, Inc.
1.6600
-5.68%
SRPT Sarepta Therapeutics, Inc.
36.43
+3.29%
SGMO Sangamo Therapeutics, Inc.
0.4700
+4.44%
DNA Ginkgo Bioworks Holdings, Inc.
7.93
+3.39%